Andrew Scott delivered a standout performance at the Telluride Film Festival this past Friday with his world premiere in “Elsinore,” directed by Simon Stone and written by Stephen Beresford. The film chronicles the final year of Scottish actor Ian Charleson, known for “Chariots of Fire,” who played Hamlet at London’s National Theatre while secretly battling AIDS before dying in 1990 at age 40.
Scott, who previously earned acclaim for his own London production of Hamlet, portrays Charleson with a blend of wit, vanity, and grace. The casting is viewed as a career milestone for the actor, who has never received an Oscar nomination despite critical praise for roles in projects like “All of Us Strangers.” “Elsinore” is being hailed as the correction he has long awaited, with Scott delivering a high-wire performance that resonates with voters accustomed to honoring portrayals of actors facing mortality.
The film carries significant historical weight, depicting a real man’s final act of defiance. Industry observers note that no openly gay man has ever won the Academy Award for Best Actor, making Scott a historic candidate if he prevails. His performance is supported by Olivia Colman as Charleson’s doctor, delivering a turn described as both steel and mischief, and Billie Piper in a quiet but impactful role as a casting director and confidante.
For “Elsinore” to convert Scott’s performance into a trophy, the film will need broader recognition beyond lead actor support. Historically, lone acting nominations are precarious, and the project may need nominations for supporting performances, screenplay, or technical categories, along with a Best Picture nod, to secure a win. Focus Features has a strong track record in this arena, having produced five Best Actor winners from biopics over the last 25 years, all of which were also Best Picture nominees.
The studio is already leveraging its recent Oscar success, including Jessie Buckley’s win for “Hamnet” and Kenneth Branagh’s earlier victory for “Belfast.” With “Elsinore” following the blueprint of past award-season hits and centering on Shakespeare’s most famous role, the film arrives with substantial pedigree. Festival audiences responded enthusiastically to the premiere, suggesting the Bard may indeed help anoint Scott with the industry’s highest honor.
Historic win if he takes it. Scott’s depth here is undeniable, and the industry is finally ready for this milestone.
Ian Charleson’s story deserves this spotlight. Seeing Scott embody his vulnerability and wit is exactly the correction he’s been waiting for.
Focus Features has a great track record with biopics, but can a lone lead nomination really win without Best Picture support?
Olivia Colman as the doctor? Yes please. Their dynamic sounds electric and might just steal the scene from Scott.